Related Experiment Video
Updated: Feb 18, 2026

RhoC GTPase Activation Assay
Published on: August 22, 2010
The Rho GTPase signalling pathway in urothelial carcinoma
Solomon L Woldu1, Ryan C Hutchinson1, Laura-Maria Krabbe1
1University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, Texas 75390-9110, USA.
Abstract:
Urothelial carcinoma remains a clinical challenge: non-muscle-invasive disease has a high rate of recurrence and risk of progression, and outcomes for patients with advanced disease are poor, owing to a lack of effective systemic therapies. The Rho GTPase family of enzymes was first identified >30 years ago and contains >20 members, which are divided into eight subfamilies: Cdc42, Rac, Rho, RhoUV, RhoBTB, RhoDF, RhoH, and Rnd. Rho GTPases are molecular on-off switches, which are increasingly being understood to have a critical role in a number of cellular processes, including cell migration, cell polarity, cell adhesion, cell cycle progression, and regulation of the cytoskeleton. This switch is an evolutionarily conserved system in which GTPases alternate between GDP-bound (inactive) and GTP-bound (active) forms. The activities of these Rho GTPases are many, context-dependent, and regulated by a number of proteins that are being progressively elucidated. Aberrations of the Rho GTPase signalling pathways have been implicated in various malignancies, including urothelial carcinoma, and understanding of the role of Rho GTPases in these diseases is increasing. This signalling pathway has the potential for therapeutic targeting in urothelial carcinoma. Research in this area is nascent, and much work is necessary before current laboratory-based research can be translated into the clinic.
Insights
Urothelial carcinoma poses treatment challenges. Rho GTPase signaling pathways are implicated in this cancer and may offer future therapeutic targets.
Area of Science:
- Oncology
- Molecular Biology
- Cell Signaling
Background:
- Urothelial carcinoma presents significant clinical challenges, with high recurrence rates for non-muscle-invasive disease and poor outcomes for advanced stages due to limited systemic therapies.
- The Rho GTPase family, comprising over 20 enzymes, plays crucial roles in fundamental cellular processes like migration, polarity, adhesion, cell cycle, and cytoskeleton regulation.
Purpose of the Study:
- To explore the role of Rho GTPase signaling pathways in urothelial carcinoma.
- To investigate the potential of targeting Rho GTPase pathways for therapeutic intervention in urothelial carcinoma.
Main Methods:
- Review of existing literature on Rho GTPase function and their implication in malignancies.
- Analysis of the current understanding of Rho GTPase aberrations in urothelial carcinoma.
Main Results:
- Rho GTPases function as molecular switches, cycling between inactive (GDP-bound) and active (GTP-bound) states.
- Aberrations in Rho GTPase signaling pathways are increasingly linked to various cancers, including urothelial carcinoma.
Conclusions:
- The Rho GTPase signaling pathway is a promising area for therapeutic targeting in urothelial carcinoma.
- Current research is in its early stages, requiring further investigation to translate laboratory findings into clinical applications.
More Related Videos
13:51Detection of Small GTPase Prenylation and GTP Binding Using Membrane Fractionation and GTPase-linked Immunosorbent Assay
Published on: November 11, 2018
11:28Affinity Precipitation of Active Rho-GEFs Using a GST-tagged Mutant Rho Protein GST-RhoAG17A from Epithelial Cell Lysates
Published on: March 31, 2012
Related Concept Videos
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
GTPases and their Regulation
Large G-proteins,...
GTPases and their Regulation
Activation and Inactivation of G Proteins
The Ras Gene
Ras is a...
Amplifying Signals via Enzymatic Cascade